An Crepel Belgian Reimbursement Update - September 2026 September 2026 brings a substantial Belgian reimbursement update, with relevant patient access changes across oncology, pulmonary arterial hypertension, rare diseases, transplantation, dermatology, ne... Aug 28, 2026
An Crepel Belgian Reimbursement Update - August 2026 The Belgian reimbursement changes effective 1 August 2026 introduce several new treatment options, alongside targeted closures and practical improvements in prescribing and renewal. Below is a curated... Jul 30, 2026
An Crepel Belgian Reimbursement Update – July 2026 Targeted access gains, tighter legacy routes The July 2026 update shows three clear signals. First, access broadening continues in selected high-need and specialist-driven areas, particularly in infla... Jun 28, 2026
An Crepel Belgian Reimbursement Update – June 2026 Selected access changes across key treatment areas June 2026 brings a diverse Belgian reimbursement update, with relevant patient access changes across osteoporosis, rare diseases, vaccines, oncology,... May 28, 2026
An Crepel Belgian Reimbursement Update - May 2026 Immuno-oncology, hATTR and neurology stand out The Belgian reimbursement update effective 1 May 2026 is a broad one, but not every change carries the same market access signal. Several updates are adm... Apr 27, 2026
